Anzeige
Erschienen in:
01.11.2011 | Reproductive Medicine
Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes
Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2011
Einloggen, um Zugang zu erhaltenAbstract
Objective
To evaluate the association between different basal serum levels of anti-Müllerian hormone (AMH) and oocyte-embryo quality and IVF outcomes.
Materials and methods
Two hundred and nine infertile women who underwent in vitro fertilization treatment with intracytoplasmic sperm injection (ICSI) between January 2009 and February 2011 were included in the study. Mean age, BMI, FSH, E2, inhibin B, duration of infertility, total gonadotropin dose, antral follicle count, morphology of all oocytes, percentage of MII, early cleavage rate, the number of good quality embryos in transfer and ongoing pregnancy (>12 weeks) rates were evaluated.
Results
Six groups were formed according to the percentiles as <10% (≤0.89 ng/ml; n = 21), 10–25% (0.89–1.40 ng/ml; n = 31), 25–50% (1.40–2.89 ng/ml; n = 53), 50–75% (2.89–4.83 ng/ml; n = 28), 75–90% (4.83–8.06 ng/ml; n = 55), >90% (>8.06 ng/ml; n = 21). Central granulation, cytoplasmic granulation, oocyte postmaturity, percentage of embryos, early cleavage and percentage of transferred good quality embryos were significantly different in five groups (ANOVA test). Ongoing pregnancy rate (PR) was the lowest in <10% (9.5%), and the highest in 50–75% group (39.3%). (P = 0.040)
Conclusion
Different AMH levels may predict the quality of oocytes, presence of postmaturity and nucleoli Z score, early cleavage and ICSI outcomes.